The legacy of Viagra, and its creator copyright, presents a complex case study for investors. At first a blockbuster drug, yielding billions in revenue , its exclusivity period created a deluge of lower-priced alternatives , significantly eroding its market share . While specific firms may seek to capitalize on related treatments , the present land